openPR Logo
Press release

Pharmacovigilance Market to Reach USD 15.2 Billion by 2034

11-12-2025 01:03 PM CET | Health & Medicine

Press release from: Exactitude Consultancy

Pharmacovigilance

Pharmacovigilance

Pune, India, November 11, 2025 - The global Pharmacovigilance Market is projected to expand from USD 8.9 billion in 2024 to USD 15.2 billion by 2034, registering a CAGR of 5.5 %, according to Exactitude Consultancy. Growing emphasis on drug-safety analytics, post-marketing surveillance, and AI-powered adverse-event detection is reshaping pharmacovigilance across the global life-sciences ecosystem.

Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/50028

Key Takeaways
• Market Size (2024): USD 8.9 Billion
• Forecast (2034): USD 15.2 Billion
• CAGR (2025 - 2034): 5.5 %
• Leading Companies: IQVIA Inc., Parexel International Corp., Oracle Corp., Cognizant Technology Solutions Corp., Capgemini SE, ArisGlobal LLC, ICON plc, Labcorp Drug Development, and Syneos Health Inc.
• Core Services: Case Processing & Adverse-Event Reporting | Signal Detection | Risk Management | Data Integration & AI Analytics.

Market Story
Pharmacovigilance has evolved from manual case tracking to real-time, AI-driven safety intelligence. Regulatory agencies like the U.S. FDA and EMA are intensifying post-marketing requirements, pushing pharma and CRO players to invest in advanced automation, machine learning, and cloud databases.

The integration of natural-language processing (NLP) and predictive analytics is enabling early signal detection and pattern recognition from clinical, EHR, and social-media data sources. As clinical trial complexity and biologic approvals increase, global pharmacovigilance networks are becoming the cornerstone of regulatory compliance and patient safety.

Market Segmentation
• By Service Type: Pre-clinical Safety Data Management | Clinical Trial Phase Monitoring | Post-Marketing Surveillance | Specialty Adverse Event Management

• By Process Flow: Case Data Management | Signal Detection | Risk Management | Data Mining & Analytics

• By End User: Pharmaceutical & Biotech Companies | Contract Research Organizations (CROs) | Hospitals | Regulatory Agencies

• By Region:
o North America: Largest market driven by FDA E2B(R3) mandates and mature pharma outsourcing.
o Europe: Strong focus on EudraVigilance and GDPR-compliant data platforms.
o Asia Pacific: Fastest growth due to CRO expansion in India and pharmacovigilance outsourcing in Japan & China.
o Latin America & MEA: Improving regulatory frameworks and WHO-backed drug-safety initiatives.

Explore Full Report here: https://exactitudeconsultancy.com/reports/50028/pharmacovigilance-market

Recent Developments
• 2025: IQVIA launched an AI-enabled pharmacovigilance suite integrated with EHR systems for real-time adverse-event tracking.
• 2024: Oracle expanded its Argus Safety Cloud to support multi-regional signal analytics and compliance automation.
• 2023: Parexel introduced blockchain-based audit trails to enhance data traceability and regulatory confidence.
• 2022: ArisGlobal partnered with Cognizant to deploy an AI-first platform for pharma risk assessment.

Expert Quote
"Pharmacovigilance is undergoing a digital revolution where AI, automation, and big-data integration are delivering faster and more reliable safety signals than ever before. This technology-driven shift is building trust and compliance across global regulatory landscapes," said Irfan Tamboli, Business Development Executive at Exactitude Consultancy.

Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=50028

Market Drivers
1. Increasing Drug Approvals and Complex Therapeutic Pipelines.
2. Regulatory Mandates for Real-Time Safety Reporting and Signal Detection.
3. Rising Pharmacovigilance Outsourcing to CROs and Technology Vendors.
4. AI and Automation Integration in Adverse-Event Analysis.

Forecast Outlook
Between 2025 and 2034, the market will see rapid adoption of cloud-native pharmacovigilance systems, digital twin monitoring, and multi-lingual adverse-event analytics. Asia Pacific will emerge as a strategic outsourcing hub while North America continues to lead in AI-driven regulatory compliance.

Conclusion
The Pharmacovigilance Market is on the brink of a new era of digital drug-safety surveillance. As biotech and pharma companies embrace predictive AI tools and integrated data ecosystems, pharmacovigilance is evolving into a strategic pillar for both innovation and regulatory trust.

This report is also available in the following languages : Japanese (医薬品安全性監視市場), Korean (약물 안전 감시 시장), Chinese (药物警戒市场), French (Marché de la pharmacovigilance), German (Pharmakovigilanzmarkt), and Italian (Mercato della farmacovigilanza), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/50028/pharmacovigilance-market#request-a-sample

Related Reports

Functional Service Providers Fsp Market
https://exactitudeconsultancy.com/reports/50301/functional-service-providers-fsp-market

U.S. Functional Service Providers Fsp Market
https://exactitudeconsultancy.com/reports/50381/u-s-functional-service-providers-fsp-market

U.S. Life Sciences Bpo Market
https://exactitudeconsultancy.com/reports/50794/u-s-life-sciences-bpo-market

Life Science Analytics Market
https://exactitudeconsultancy.com/reports/14997/life-science-analytics-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharmacovigilance Market to Reach USD 15.2 Billion by 2034 here

News-ID: 4266680 • Views:

More Releases from Exactitude Consultancy

Cold Planer Market Sees Consistent Growth Supported by Global Road Rehabilitation and Infrastructure Projects
Cold Planer Market Sees Consistent Growth Supported by Global Road Rehabilitatio …
The global cold planer market is experiencing steady growth as governments and private contractors increase spending on road rehabilitation, resurfacing, and infrastructure modernization. Cold planers, also known as milling machines, are widely used to remove damaged asphalt and concrete surfaces efficiently, supporting sustainable road construction practices. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68250 Key Market Highlights • Increasing focus on road maintenance and resurfacing projects • Growing demand for efficient and precision milling
Credit Management Software Market Accelerates as Organizations Focus on Risk Mitigation and Cash Flow Optimization
Credit Management Software Market Accelerates as Organizations Focus on Risk Mit …
The global credit management software market is witnessing robust growth as organizations across industries adopt digital solutions to manage credit risk, improve receivables performance, and strengthen financial controls. Credit management software enables businesses to automate credit scoring, monitor customer creditworthiness, and streamline collections processes. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68248 Key Market Highlights • Growing adoption of automated credit risk assessment tools • Increasing focus on working capital and cash flow management • Integration
Session Border Controller Market Expands Rapidly as Enterprises and Telecom Operators Strengthen Network Security
Session Border Controller Market Expands Rapidly as Enterprises and Telecom Oper …
The global session border controller (SBC) market is experiencing strong growth as telecom operators and enterprises increasingly deploy SBC solutions to secure, manage, and optimize real-time IP communications. SBCs play a critical role in protecting voice over IP (VoIP), unified communications (UC), and multimedia sessions from cyber threats while ensuring interoperability and quality of service. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68246 Key Market Highlights • Growing adoption of VoIP and
Biofuel Market Including E-Methane and Sustainable Aviation Fuel Gains Strong Traction Amid Global Decarbonization Efforts
Biofuel Market Including E-Methane and Sustainable Aviation Fuel Gains Strong Tr …
The global biofuel market, encompassing e-methane, sustainable aviation fuel (SAF), and other advanced biofuels, is witnessing robust growth as governments and industries intensify efforts to reduce carbon emissions and transition toward cleaner energy sources. These fuels play a critical role in achieving net-zero targets while enabling decarbonization of hard-to-abate sectors such as aviation, shipping, and heavy transportation. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68244 Key Market Highlights • Rapid growth of

All 5 Releases


More Releases for Pharmacovigilance

Top Pharmacovigilance Companies Analysis By 2031
The Pharmacovigilance Market is expected to register a CAGR of 6.6% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031. Download PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00003127?utm_source=OpenPR&utm_medium=10379 The List of Companies • #Accentures • Bristol-Myers Squibb Company • Linical Accelovance • Cognizant • Covance Inc. • F. Hoffmann-La Roche Ltd. • GlaxoSmithKline plc. • ICON plc • Capgemini (IGATE Corporation) Clinical
Pharmacovigilance - Scope and Research Methodology
The Pharmacovigilance Market is expected to register a CAGR of 6.6% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031. The Pharmacovigilance Market report covers analysis by Clinical Trial Phase (Pre-Clinical, Phase I, Phase II, Phase III, and Phase IV), Service Provider (In-House and Contract Outsourcing), Type of Method (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event
Pharmacovigilance World 2025 Conference & Expo
We are delighted to welcome you to the Pharmacovigilance World 2025, and we are confident that your active participation will contribute to the advancement of drug safety practices. Together, let us strive towards a safer and more vigilant healthcare system that prioritizes patient well-being and ensures the continued benefit of medications worldwide. As medical science advances, so does our understanding of drug safety and the need for vigilance when it comes
Top Factor Driving Pharmacovigilance Market Growth in 2025: Research And Develop …
How Are the key drivers contributing to the expansion of the pharmacovigilance market? The escalation in research and development undertakings stimulates growth in the pharmacovigilance market. Pharmaceutical organizations can create novel and superior drugs through enhanced safety profiles by allocating resources to R&D. The intensive testing in preclinical and clinical stages during the drug development protocol allows early recognition of potential safety issues, paving the way for adequate risk reduction approaches.
Monitoring Medication Safety with Pharmacovigilance
Pharmacovigilance (PV) is defined as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem. Pharmacovigilance plays a significant role in pharmaceutical and biotechnological sectors in designing of drugs and their interactions. The pharmacovigilance involves collecting information from healthcare providers and patients to know about the hazards associated with medications. Download Sample PDF at: https://www.theinsightpartners.com/sample/TIPRE00003127?utm_source=OpnePR&utm_medium=10776 Increasing cases of adverse drug reactions
Pharmacovigilance Market Opportunity Analysis by 2028
Pharmacovigilance Market: Introduction According to the report, the global pharmacovigilance market was valued at US$ 6.1 Bn in 2020 and is projected to expand at a CAGR of 8.8% from 2021 to 2028. Pharmacovigilance activities are defined as science used for detection, assessment, understanding, and prevention of adverse effects of drugs and vaccines. Drugs and vaccines go through rigorous testing in the clinical trials to check their safety and efficacy before